Teza Capital Management LLC Boosts Stock Holdings in Tenet Healthcare Co. (NYSE:THC)

Teza Capital Management LLC increased its holdings in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 61.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,141 shares of the company's stock after acquiring an additional 4,244 shares during the period. Teza Capital Management LLC's holdings in Tenet Healthcare were worth $1,406,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in THC. Colonial Trust Co SC lifted its position in shares of Tenet Healthcare by 85.7% during the fourth quarter. Colonial Trust Co SC now owns 247 shares of the company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. GeoWealth Management LLC boosted its holdings in Tenet Healthcare by 39.8% in the fourth quarter. GeoWealth Management LLC now owns 295 shares of the company's stock valued at $37,000 after acquiring an additional 84 shares during the last quarter. WR Wealth Planners LLC boosted its stake in shares of Tenet Healthcare by 2,836.4% in the 4th quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after purchasing an additional 312 shares during the last quarter. Smartleaf Asset Management LLC grew its position in shares of Tenet Healthcare by 30.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock worth $59,000 after buying an additional 110 shares during the period. Finally, Kestra Investment Management LLC acquired a new position in Tenet Healthcare in the fourth quarter valued at approximately $60,000. Institutional investors own 95.44% of the company's stock.

Tenet Healthcare Stock Performance

Shares of NYSE:THC traded down $1.73 during trading on Thursday, reaching $161.10. 857,987 shares of the stock were exchanged, compared to its average volume of 1,534,835. Tenet Healthcare Co. has a 12 month low of $109.82 and a 12 month high of $171.20. The stock has a 50-day moving average price of $135.48 and a 200-day moving average price of $136.64. The firm has a market cap of $14.96 billion, a PE ratio of 5.00, a PEG ratio of 1.02 and a beta of 1.63. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share for the quarter, beating analysts' consensus estimates of $3.11 by $1.25. The firm had revenue of $5.22 billion for the quarter, compared to analyst estimates of $5.15 billion. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. The company's quarterly revenue was down 2.5% on a year-over-year basis. During the same quarter last year, the business posted $3.22 earnings per share. Research analysts expect that Tenet Healthcare Co. will post 12.24 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. UBS Group raised their target price on Tenet Healthcare from $217.00 to $230.00 and gave the stock a "buy" rating in a report on Wednesday, April 30th. Truist Financial raised their price objective on Tenet Healthcare from $175.00 to $190.00 and gave the stock a "buy" rating in a research note on Monday, May 12th. Morgan Stanley increased their price target on Tenet Healthcare from $165.00 to $175.00 and gave the stock an "overweight" rating in a report on Monday, May 5th. Robert W. Baird reissued a "neutral" rating and set a $137.00 target price (down from $153.00) on shares of Tenet Healthcare in a research note on Tuesday, April 15th. Finally, Baird R W cut shares of Tenet Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Five analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $174.94.

Insider Buying and Selling

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the sale, the director now owns 27,378 shares of the company's stock, valued at approximately $3,434,022.54. This trade represents a 25.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Paola M. Arbour sold 6,461 shares of Tenet Healthcare stock in a transaction dated Thursday, May 15th. The shares were sold at an average price of $160.20, for a total value of $1,035,052.20. Following the transaction, the executive vice president now owns 27,848 shares of the company's stock, valued at $4,461,249.60. This trade represents a 18.83% decrease in their position. The disclosure for this sale can be found here. Insiders sold 20,987 shares of company stock valued at $2,972,421 over the last quarter. Insiders own 0.81% of the company's stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.